Published mark
Elevance Health
Elevance Health, Inc.
NYSE: ELV. Canonical company identity and public leadership record.
US
Record source reportedRecord not claimedNo Eval published
- Alpha ID
- alpha:company:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b
- SEC CIK
- 0001156039
- Website
- www.elevancehealth.com Open
- Record version
- vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 16, 2026
- Newest evidence
- Mar 27, 2026
- Monitoring
- Not yet monitored Details
- Integrity
- Not yet signed Methodology
- CEO
- Gail K. BoudreauxSince Feb 6, 2026
- Chair
- Not published
- Independent
- Not published2 directors published
- Published claims
- 555 distinct sources
- Evidence records
- 260 pinned
- Source conflicts
- 0None open
Built from 5 distinct sources and 26 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.
CorroboratedSource reportedAlpha inferenceNot disclosed
Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works
DIRECTOR APPOINTED
Amy W. Schulman seat on Elevance Health, effective 2026-03-27.
EffectiveEffective Mar 27, 2026E3
Monitoring
ContinuousWhat the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.
- IdentityunclaimedPublished
- Evidencesource_reportedPublished
- Evaluationnot_evaluatedPublished
- MonitoringNot yet published for this record.Not published
- AuthorityNot yet published for this record.Not published
- FreshnesscurrentPublished
Leadership
Evidence| Role | Person | Since | Status | Claim |
|---|---|---|---|---|
| Executive Vice President and President, Commercial Health Benefits | Charles M. Kendrick, Jr. | Feb 2026 | current | Source reportedE16 |
| Executive Vice President and Chief Legal Officer | Erin M. Wessling | Feb 2026 | current | Source reportedE17 |
| Executive Vice President and President, Government Health Benefits | Felicia F. Norwood | Feb 2026 | current | Source reportedE18 |
| President and Chief Executive Officer | Gail K. Boudreaux | Feb 2026 | current | Source reportedE19 |
| Executive Vice President and Chief Financial Officer | Mark B. Kaye | Feb 2026 | current | Source reportedE20 |
| Executive Vice President and President, Carelon and CarelonRx | Peter D. Haytaian | Feb 2026 | current | Source reportedE21 |
| Executive Vice President and Chief Digital and Information Officer | Ratnakar V. Lavu | Feb 2026 | current | Source reportedE22 |
| Chief Accounting Officer and Controller | Ronald W. Penczek | Feb 2026 | current | Source reportedE23 |
| Executive Vice President and Chief Human Resources Officer | Ryan R. Craig | Feb 2026 | current | Source reportedE24 |
Board of directors
Evidence2 directors published. Independence determinations are not published for every director.
| Director | Status | Since | Committees | Claim |
|---|---|---|---|---|
| Amy W. Schulman | Independence not published | 2026 | AuditAudit; FinanceFinance | Source reportedE3 |
| Steven H. Collis | Independence not published | 2026 | AuditAudit; FinanceFinance | Source reportedE14 |
| Antonio F. Neri | Independence not published | Not published | Compensation and Talent, chairCompensation and Talent · Chair; GovernanceGovernance | Source reportedE4 |
| Bahija Jallal | Independence not published | Not published | Compensation and TalentCompensation and Talent; Governance · ChairGovernance, chair | Source reportedE5 |
| Deanna D. Strable | Independence not published | Not published | AuditAudit; GovernanceGovernance | Source reportedE6 |
| Elizabeth E. Tallett | Independence not published | Not published | None published | Source reportedE7 |
| Gail K. Boudreaux | Independence not published | Not published | None published | Source reportedE8 |
| Lewis Hay, III | Independence not published | Not published | AuditAudit; FinanceFinance | Source reportedE9 |
| R. Kerry Clark | Independence not published | Not published | None published | Source reportedE10 |
| Ramiro G. Peru | Independence not published | Not published | Compensation and TalentCompensation and Talent; GovernanceGovernance | Source reportedE11 |
| Robert L. Dixon, Jr. | Independence not published | Not published | Compensation and TalentCompensation and Talent; FinanceFinance | Source reportedE12 |
| Ryan M. Schneider | Independence not published | Not published | Audit, chairAudit · Chair; GovernanceGovernance | Source reportedE13 |
| Susan D. DeVore | Independence not published | Not published | Compensation and TalentCompensation and Talent; FinanceFinance | Source reportedE15 |
Committees and risk ownership
Evidence| Committee | Chair | Members | Risks assigned |
|---|---|---|---|
| Audit | Ryan M. Schneider | Ryan M. Schneider, Amy W. Schulman, Deanna D. Strable, Lewis Hay, III, Steven H. Collis | Not described in the published record |
| Audit · Chair; Governance | Not published | Ryan M. Schneider | Not described in the published record |
| Audit; Finance | Not published | Amy W. Schulman, Lewis Hay, III, Steven H. Collis | financial |
| Audit; Governance | Not published | Deanna D. Strable | Not described in the published record |
| Compensation and Talent | Antonio F. Neri | Antonio F. Neri, Bahija Jallal, Ramiro G. Peru, Robert L. Dixon, Jr., Susan D. DeVore | human_capital |
| Compensation and Talent · Chair; Governance | Not published | Antonio F. Neri | human_capital |
| Compensation and Talent; Finance | Not published | Robert L. Dixon, Jr., Susan D. DeVore | human_capital, financial |
| Compensation and Talent; Governance | Not published | Ramiro G. Peru | human_capital |
| Compensation and Talent; Governance · Chair | Not published | Bahija Jallal | human_capital |
| Finance | Not published | Amy W. Schulman, Lewis Hay, III, Robert L. Dixon, Jr., Steven H. Collis, Susan D. DeVore | financial |
| Governance | Bahija Jallal | Bahija Jallal, Antonio F. Neri, Deanna D. Strable, Ramiro G. Peru, Ryan M. Schneider | Not described in the published record |
Committee RecordAudit: Chair Ryan M. Schneider; Members Ryan M. Schneider (Chair); Amy W. Schulman; Deanna D. Strable; Lewis Hay, III; Steven H. Collis
Committee AppointmentRyan M. Schneider: chair, Audit
Committee AppointmentAmy W. Schulman: member, Audit
Committee AppointmentDeanna D. Strable: member, Audit
Committee AppointmentLewis Hay, III: member, Audit
Committee AppointmentSteven H. Collis: member, Audit
Committee RecordCompensation and Talent: Chair Antonio F. Neri; Members Antonio F. Neri (Chair); Bahija Jallal; Ramiro G. Peru; Robert L. Dixon, Jr.; Susan D. DeVore
Committee AppointmentAntonio F. Neri: chair, Compensation and Talent
Committee AppointmentBahija Jallal: member, Compensation and Talent
Committee AppointmentRamiro G. Peru: member, Compensation and Talent
Committee AppointmentRobert L. Dixon, Jr.: member, Compensation and Talent
Committee AppointmentSusan D. DeVore: member, Compensation and Talent
Committee RecordFinance: Chair not stated; Members Amy W. Schulman; Lewis Hay, III; Robert L. Dixon, Jr.; Steven H. Collis; Susan D. DeVore
Committee AppointmentAmy W. Schulman: member, Finance
Committee AppointmentLewis Hay, III: member, Finance
Committee AppointmentRobert L. Dixon, Jr.: member, Finance
Committee AppointmentSteven H. Collis: member, Finance
Committee AppointmentSusan D. DeVore: member, Finance
Committee RecordGovernance: Chair Bahija Jallal; Members Bahija Jallal (Chair); Antonio F. Neri; Deanna D. Strable; Ramiro G. Peru; Ryan M. Schneider
Committee AppointmentBahija Jallal: chair, Governance
Committee AppointmentAntonio F. Neri: member, Governance
Committee AppointmentDeanna D. Strable: member, Governance
Committee AppointmentRamiro G. Peru: member, Governance
Committee AppointmentRyan M. Schneider: member, Governance
Control and voting power
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Authority to act
Evidence and agent registryWho can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.
Principal executive officerGail K. Boudreaux, President and Chief Executive Officer, from Feb 6, 2026
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
Financials and market context
EvidenceIndex MembershipS&P 500 (SPX)
Security ListingELV (NYSE)
Index memberships1 membership attached to a specific security and listing.Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.
SPX
Source reportedAs of Oct 16, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.
| Index | Security | Status | Effective | Verification | Source |
|---|---|---|---|---|---|
| S&P 500 (S&P Dow Jones Indices) | NYSE: ELV | current | Jul 25, 2002 | inferred | Slickcharts S&P 500 constituent table (public observation, not S&P DJI license) |
Governance and policies
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Risk, audit, and cyber
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
AI oversight and accountability
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Legal and regulatory
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Compensation
EvidenceNo published claims
Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.
Other published claims
EvidencePublished Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.
Legal NameElevance Health, Inc.
Entity StatusPublic listing published
Official Websitehttps://www.elevancehealth.com
Published FactUS
Published FactIN
Published FactHealthcare
Published Facthttps://www.elevancehealth.com
Not yet in this record
CoverageA gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.
- Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
- OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
- FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
- CompensationNot reviewed. Pay design shows how incentives are governed.
- GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
- Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
- AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
- LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
- RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
- CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
- AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.
Linked people
Same claims as person records- Charles M. Kendrick, Jr.Executive Vice President and President, Commercial Health Benefitscompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:22
- Erin M. WesslingExecutive Vice President and Chief Legal Officercompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:23
- Felicia F. NorwoodExecutive Vice President and President, Government Health Benefitscompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:24
- Gail K. BoudreauxPresident and Chief Executive Officer; Directorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:25, company:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:14
- Mark B. KayeExecutive Vice President and Chief Financial Officercompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:26
- Peter D. HaytaianExecutive Vice President and President, Carelon and CarelonRxcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:27
- Ratnakar V. LavuExecutive Vice President and Chief Digital and Information Officercompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:28
- Ronald W. PenczekChief Accounting Officer and Controllercompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:29
- Ryan R. CraigExecutive Vice President and Chief Human Resources Officercompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:30
- Amy W. SchulmanDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:9
- Steven H. CollisDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:20
- Antonio F. NeriDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:10
- Bahija JallalDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:11
- Deanna D. StrableDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:12
- Elizabeth E. TallettDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:13
- Lewis Hay, IIIDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:15
- R. Kerry ClarkDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:16
- Ramiro G. PeruDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:17
- Robert L. Dixon, Jr.Directorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:18
- Ryan M. SchneiderDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:19
- Susan D. DeVoreDirectorcompany:7fd4a49e-82d0-4ba4-b396-6d43d3bb4f1b:leadership_role:21
Subject and corrections
Public-role doctrineThis record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.
- Basis
- Published company record built from public sources
- Sources
- 26 evidence records cited. 0 with redistribution rights.
- Never published
- Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
- Record claimed
- No
- Open disputes
- 0
- Identity ownership
- unclaimed
Claiming not yet available
If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.
Evidence
Authority and rights- E1Alpha canonical company public projection. canonical identity. Retrieved Oct 16, 2026. Cited by 6 Claims.
- E2Elevance Health, Inc. Form 10-K (filed 2026-02-06). SEC filing. Retrieved Aug 29, 2026. Cited by 2 Claims.
- E3sec filing. Published Mar 27, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E4sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E5sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E6sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E7sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E8sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E9sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E10sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E11sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E12sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E13sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E14sec filing. Published Mar 27, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
- E15sec filing. Published Mar 28, 2025. Retrieved May 3, 2026. Cited by 1 Claim.
- E16sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E17sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E18sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E19sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E20sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E21sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E22sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E23sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E24sec filing. Published Feb 6, 2026. Retrieved May 4, 2026. Cited by 1 Claim.
- E25board_seats. sp500-board-director-completeness-remediation-2026-05-15. Cited by 24 Claims.
- E26Slickcharts S&P 500 constituent table (public observation, not S&P DJI license). index provider. Retrieved Sep 2, 2026. Cited by 1 Claim.
What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 16, 2026- Amy W. Schulman seat on Elevance Health, effective 2026-03-27.
- Steven H. Collis seat on Elevance Health, effective 2026-03-27.
- Audit; Finance committee of Elevance Health, effective 2026-03-27.
- Amy W. Schulman member of Audit; Finance, effective 2026-03-27.
- Steven H. Collis member of Audit; Finance, effective 2026-03-27.
- Charles M. Kendrick, Jr. executive of Elevance Health, effective 2026-02-06.
- Erin M. Wessling executive of Elevance Health, effective 2026-02-06.
- Felicia F. Norwood executive of Elevance Health, effective 2026-02-06.
- Gail K. Boudreaux executive of Elevance Health, effective 2026-02-06.
- Mark B. Kaye executive of Elevance Health, effective 2026-02-06.
- Peter D. Haytaian executive of Elevance Health, effective 2026-02-06.
- Ratnakar V. Lavu executive of Elevance Health, effective 2026-02-06.
- Ronald W. Penczek executive of Elevance Health, effective 2026-02-06.
- Ryan R. Craig executive of Elevance Health, effective 2026-02-06.